157 related articles for article (PubMed ID: 37678877)
1. Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at High Altitude.
Huang H; Yang L
Altern Ther Health Med; 2023 Nov; 29(8):689-693. PubMed ID: 37678877
[TBL] [Abstract][Full Text] [Related]
2. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
3. Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure.
El Alam S; Pena E; Aguilera D; Siques P; Brito J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293512
[TBL] [Abstract][Full Text] [Related]
4. Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension.
Udjus C; Cero FT; Halvorsen B; Behmen D; Carlson CR; Bendiksen BA; Espe EKS; Sjaastad I; Løberg EM; Yndestad A; Aukrust P; Christensen G; Skjønsberg OH; Larsen KO
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L999-L1012. PubMed ID: 30908936
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
6. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.
Ikari J; Nelson AJ; Obaid J; Giron-Martinez A; Ikari K; Makino F; Iwasawa S; Gunji Y; Farid M; Wang X; Basma H; Demeo D; Feghali-Bostwick C; Holz O; Rabe K; Liu X; Rennard SI
PLoS One; 2017; 12(9):e0184039. PubMed ID: 28880936
[TBL] [Abstract][Full Text] [Related]
7. Role for interleukin-6 in COPD-related pulmonary hypertension.
Chaouat A; Savale L; Chouaid C; Tu L; Sztrymf B; Canuet M; Maitre B; Housset B; Brandt C; Le Corvoisier P; Weitzenblum E; Eddahibi S; Adnot S
Chest; 2009 Sep; 136(3):678-687. PubMed ID: 19349390
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
[TBL] [Abstract][Full Text] [Related]
9. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.
Liu J; Wang W; Wang L; Chen S; Tian B; Huang K; Corrigan CJ; Ying S; Wang W; Wang C
EBioMedicine; 2018 Jul; 33():196-210. PubMed ID: 29921553
[TBL] [Abstract][Full Text] [Related]
10. Reactive Oxygen Species in COPD-Related Vascular Remodeling.
Zuo L; Chuang CC; Clark AD; Garrison DE; Kuhlman JL; Sypert DC
Adv Exp Med Biol; 2017; 967():399-411. PubMed ID: 29047102
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function.
Lin X; Fan Y; Wang X; Chi M; Li X; Zhang X; Sun D
Am J Med Sci; 2017 Oct; 354(4):388-394. PubMed ID: 29078843
[TBL] [Abstract][Full Text] [Related]
12. NOX4 expression and distal arteriolar remodeling correlate with pulmonary hypertension in COPD.
Guo X; Fan Y; Cui J; Hao B; Zhu L; Sun X; He J; Yang J; Dong J; Wang Y; Liu X; Chen J
BMC Pulm Med; 2018 Jul; 18(1):111. PubMed ID: 29986678
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH.
Choudhury P; Dasgupta S; Kar A; Sarkar S; Chakraborty P; Bhattacharyya P; Roychowdhury S; Chaudhury K
Respir Med; 2024 Jun; 227():107658. PubMed ID: 38704051
[TBL] [Abstract][Full Text] [Related]
14. A systematical strategy for quality markers screening of different methods processing Platycodonis radix based on phytochemical analysis and the impact on Chronic Obstructive Pulmonary Disease.
Bai T; Guo J; Deng Y; Zheng Y; Shang J; Zheng P; Liu M; Yang M; Zhang J
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117311. PubMed ID: 37827295
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 overexpression induces pulmonary hypertension.
Steiner MK; Syrkina OL; Kolliputi N; Mark EJ; Hales CA; Waxman AB
Circ Res; 2009 Jan; 104(2):236-44, 28p following 244. PubMed ID: 19074475
[TBL] [Abstract][Full Text] [Related]
16. Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia.
Wojciak-Stothard B; Zhao L; Oliver E; Dubois O; Wu Y; Kardassis D; Vasilaki E; Huang M; Mitchell JA; Harrington LS; Prendergast GC; Wilkins MR
Circ Res; 2012 May; 110(11):1423-34. PubMed ID: 22539766
[TBL] [Abstract][Full Text] [Related]
17. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.
Savale L; Tu L; Rideau D; Izziki M; Maitre B; Adnot S; Eddahibi S
Respir Res; 2009 Jan; 10(1):6. PubMed ID: 19173740
[TBL] [Abstract][Full Text] [Related]
18. [Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity].
Ovsyannikov ES; Avdeev SN; Budnevsky AV
Ter Arkh; 2020 Apr; 92(3):13-18. PubMed ID: 32598787
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
Voelkel NF; Tuder RM; Bridges J; Arend WP
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review.
Wrobel JP; Thompson BR; Williams TJ
J Heart Lung Transplant; 2012 Jun; 31(6):557-64. PubMed ID: 22502811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
